Xeltis

Xeltis

HealthNetherlands

Xeltis is a commercial-stage MedTech company developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. The company aims to improve patient outcomes in hemodialysis vascular access and cardiovascular replacements, addressing significant unmet needs in these areas.

🏆 Featured in Datapile’s Q3 2026 Netherlands Funding Report

Read the Q3 2026 Netherlands report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-netherlands-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 Netherlands Funding Report</a>

Funding history

  1. $222026-07-28
    Source: news.google.com

Founder

Eliane Schutte
Eliane Schutte
Chief Executive Officer

Investors in Xeltis

Backers from this company's tracked funding rounds.

  • Horizon 3 Healthcare
  • European Innovation Council
  • Invest-NL
  • VI Partners
  • EQT Life Sciences
  • DaVita

More Health companies

Recently funded startups in the same category.

Related on Datapile